Stephen Stamp joins board at Eusa Pharma

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director.

Stephen has previously held board-level roles at Xanodyne Pharmaceuticals and Shire Pharmaceuticals, and was most recently chief financial officer at K-V Pharmaceutical Company.

Commenting on his appointment, Stephen said, “Having witnessed EUSA’s impressive growth, I am excited to be helping the company achieve its ambitious plans.

“Having already built a robust commercial infrastructure in the US and Europe, and a wider global distribution network, I believe EUSA is well placed for future success, and I welcome the opportunity to be part of the company’s continued rapid development.”

Eusa is jointly based in Oxford, UK and Langhorne, PA, in the US and focuses on in-licensing, developing and marketing late-stage oncology, pain control and critical care products.